These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10816332)

  • 1. Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart.
    Sharma A; Singh M
    Pharmacol Res; 2000 Jun; 41(6):635-40. PubMed ID: 10816332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection.
    Parikh V; Singh M
    Pharmacol Res; 1999 Aug; 40(2):129-37. PubMed ID: 10433871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart.
    Sharma A; Singh M
    Eur J Pharmacol; 2000 Oct; 406(1):85-92. PubMed ID: 11011038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart.
    Sharma A; Singh M
    Mol Cell Biochem; 2001 Mar; 219(1-2):1-6. PubMed ID: 11354240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
    Balakumar P; Rohilla A; Singh G; Singh K; Singh M
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ethylisopropyl amiloride, a Na+ - H+ exchange inhibitor, on cardioprotective effect of ischaemic and angiotensin preconditioning.
    Sharma A; Singh M
    Mol Cell Biochem; 2000 Nov; 214(1-2):31-8. PubMed ID: 11195787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Rohilla A; Singh G; Singh M; Bala kumar P
    Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin in cardioprotective effect of ischemic preconditioning.
    Sharma A; Singh M
    J Cardiovasc Pharmacol; 1999 May; 33(5):772-8. PubMed ID: 10226865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amiloride A Na+/H+ exchange inhibitor on cardioprotective effect of ischaemic preconditioning: possible involvement of resident cardiac mast cells.
    Kaur H; Parikh V; Sharma A; Singh M
    Pharmacol Res; 1997 Aug; 36(2):95-102. PubMed ID: 9344636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-delta.
    Rohilla A; Balakumar P
    Biomed Pharmacother; 2009 Dec; 63(10):787-91. PubMed ID: 19914793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.
    Parikh V; Singh M
    Mol Cell Biochem; 1999 Sep; 199(1-2):1-6. PubMed ID: 10544945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Singh G; Rohilla A; Singh M; Balakumar P
    Yakugaku Zasshi; 2009 May; 129(5):523-35. PubMed ID: 19420883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the possible mechanisms involved in adenosine preconditioning-induced cardioprotection in rats.
    Singh L; Virdi JK; Maslov LN; Singh N; Jaggi AS
    Cardiovasc Ther; 2018 Jun; 36(3):e12328. PubMed ID: 29604187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection.
    Sharma R; Randhawa PK; Singh N; Jaggi AS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):1-9. PubMed ID: 26531833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible role of adrenergic component in ischemic preconditioning.
    Sharma A; Singh M
    Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):493-9. PubMed ID: 9413833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart.
    Charan K; Goyal A; Gupta JK; Yadav HN
    J Surg Res; 2016 Apr; 201(2):272-8. PubMed ID: 27020807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats.
    Diwan V; Jaggi AS; Singh M; Singh N; Singh D
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):126-30. PubMed ID: 18287879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.
    Kansal SK; Jyoti U; Sharma S; Kaura A; Deshmukh R; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):635-41. PubMed ID: 25743572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.